Ataxia-telangiectasia is an autosomal recessive disorder caused by mutation in the ATM gene. Symptoms are characterized by progressive cerebellar ataxia, dysarthria, oculomotor apraxia, chorea/dystonia, oculocutaneous telangiectasias, endocrine dysfunction, immunodeficiency, premature aging, radiosensitivity, and predisposition to cancer. Ataxia is evident in the first year of life, and results in wheelchair dependency for most children by age of 10 years-old. Laboratory tests show raised serum alpha-fetoprotein levels. Brain MRI shows cerebellar atrophy (Figure). It may also show multiple T1 and T2 hypointense foci suggestive of hemosiderin, probably related to thrombosis and vascular leaks from multiple capillary telangiectasias1,2. There is no definitive treatment available3.
References
-
1Lin, DD, Barker PB, Lederman HM, Crawford TO. Cerebral abnormalities in
adults with ataxia-telangiectasia. AJNR Am J Neurodadiol. 2014;35(1):119-23.
http://dx.doi.org/10.3174/ajnr.A3646
» https://doi.org/10.3174/ajnr.A3646 -
2Sahama I, Sinclair K, Pannek K, Lavin M, Rose S. Radiological imaging in
ataxia telangiectasia: a review. Cerebellum. 2014;13(4):521-30.
http://dx.doi.org/10.1007/s12311-014-0557-4
» https://doi.org/10.1007/s12311-014-0557-4 -
3Chaudhary MW, Al-Baradie RS. Ataxia-telangiectasia: future prospects. Appl
Clin Genet. 2014;7:159-67. http://dx.doi.org/10.2147/TACG.S35759
» https://doi.org/10.2147/TACG.S35759

